MADISON, N.J., Jan. 5, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco. Steve Rusckowski, Chairman, President and CEO, will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Wednesday, January 11, 2017 at 5:30 p.m. Eastern Time.
The presentation will be webcast live during the conference and will be available to registered investors on the following site: http://jpmorgan.metameetings.com/confbook/healthcare17/directlink.php?p=22814 and to the public on the company's investor relations page which can be accessed at www.QuestDiagnostics.com. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until February 12, 2017.
About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 43,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.
Shawn Bevec (Investors): 973-520-2900
Dennis Moynihan (Media): 973-520-2800
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-35th-annual-jp-morgan-healthcare-conference-300386504.html
SOURCE Quest Diagnostics